List of SBIR/STTR awards granted to Chimerna Therapeutics, Inc.
Chimerna Therapeutics, Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Chimerna Therapeutics, Inc. in September, 2021 for $433,356.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS122654-01 | Phase I | 433,356 | September 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Chimerna Therapeutics, Inc. in August, 2020 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HG011214-01 | Phase I | 225,000 | August 3, 2020 | |||||||
A SBIR Phase I contract was awarded to Chimerna Therapeutics, Inc. in August, 2020 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM139433-01 | Phase I | 225,000 | August 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Chimerna Therapeutics, Inc. in September, 2022 for $586,018.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM139433-02A1 | Phase II | 586,018 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Chimerna Therapeutics, Inc. in September, 2022 for $256,158.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS129441-01 | Phase I | 256,158 | September 8, 2022 | |||||||
A SBIR Phase I contract was awarded to Chimerna Therapeutics, Inc. in June, 2022 for $255,236.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK133031-01 | Phase I | 255,236 | June 17, 2022 |
